earnings beatTRMBfinnhub
Trimble (TRMB) Beats Q2 Earnings Estimates by $0.09
Trimble (NASDAQ:TRMB) reported quarterly earnings results on August 12, 2026 that exceeded analyst expectations.
Read moreFeatured By
Real-time context
Company earnings results and notable reporting developments.
Trimble (NASDAQ:TRMB) reported quarterly earnings results on August 12, 2026 that exceeded analyst expectations.
Read moreAltimmune (NASDAQ:ALT) reported quarterly earnings results on August 12, 2026 that exceeded analyst expectations.
Read moreAcumen Pharmaceuticals (NASDAQ:ABOS) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreCapstone Holding (NASDAQ:CAPS) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreHumacyte (NASDAQ:HUMA) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreMetro (NASDAQ:MRU) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreMaple Leaf Foods (NASDAQ:MFI) reported quarterly earnings results on August 12, 2026 that exceeded analyst expectations.
Read moreBoyd Group Services (NYSE:BYD) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreNano One Materials (NASDAQ:NANO) reported quarterly earnings results on August 12, 2026 that exceeded analyst expectations.
Read moreAnnexon (NASDAQ:ANNX) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreAvalyn Pharma (NASDAQ:AVLN) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreUnicycive Therapeutics (NASDAQ:UNCY) reported quarterly earnings results on August 12, 2026 that exceeded analyst expectations.
Read moreCNS Pharmaceuticals (NASDAQ:CNSP) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreXilio Therapeutics (NASDAQ:XLO) reported quarterly earnings results on August 12, 2026 that exceeded analyst expectations.
Read moreLexeo Therapeutics (NASDAQ:LXEO) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreCentury Therapeutics (NASDAQ:IPSC) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreTScan Therapeutics (NASDAQ:TCRX) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read morePharvaris (NASDAQ:PHVS) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreAdagene (NASDAQ:ADAG) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreSutro Biopharma (NASDAQ:STRO) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read more